SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
Intimation of closure of Trading Window.28-06-2024
28-06-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Conference Call held on 31st May, 2024.06-06-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and financial year ended 31st March, 202431-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Financial Results30-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Financial Results30-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication related to Financial Results30-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2024
Please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 31st March, 202429-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year ended 31st March, 202429-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation under Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015.29-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended 31St March, 2024.
Statement of deviation/variation of fund raised through Preferential issue for the quarter ended 31st March, 2024.29-05-2024